Skip to main content
. 2017 Jun 13;8:685. doi: 10.3389/fimmu.2017.00685

Table 2.

Demographic data summary for all 635 PID patients.

Parameters All patients CVID Agammaglobulinemia SCID MHC class II deficiency
Number of patients 635 320 250 54 11
Gender (M/F) 444/191 179/141 237/13 24/30 4/7
Current age, mean; years (SD) 12.7 (8.2) 21.1 (15.7) 18.0 (8.5) 3.8 (4.9) 7.9 (7.8)
Age at first OPV dose, mean; years (SD) 0.6 (0.8) 0.5 (1.6) 0.4 (1.2) 1.0 (2.6) 0.6 (0.9)
Age at last dose, mean; years (SD) 2.3 (2.0) 4.3 (4.9) 3.0 (3.6) 2.2 (3.4) NA
Exposure to OPV (Y/N) 584/51 303/17 233/17 37/17 11/0
Paralytic disease 14 4 10 0 0

OPV, oral poliovirus vaccine; CVID, common variable immune deficiency; SCID, severe combined immunodeficiency; PID, primary immunodeficiency; MHC, major histocompatibility complex.